thiazoles has been researched along with ac 55649 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brann, MR; Currier, E; Eeg, A; Gauthier, NK; Hacksell, U; Lund, BW; Olsson, R; Piu, F; Sherbukhin, V | 1 |
Gudas, LJ; Jessurun, J; Tang, XH; Trasino, SE | 1 |
2 other study(ies) available for thiazoles and ac 55649
Article | Year |
---|---|
Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
Topics: Administration, Oral; Animals; Benzoates; Binding Sites; Biological Availability; Biphenyl Compounds; Cells, Cultured; Humans; Models, Molecular; Protein Isoforms; Protein Structure, Tertiary; Rats; Receptors, Retinoic Acid; Solubility; Structure-Activity Relationship; Thiazoles; Transcription, Genetic | 2005 |
Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Topics: Animals; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diet, High-Fat; Drugs, Investigational; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipid Peroxidation; Liver; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pancreas; Receptors, Retinoic Acid; Thiazoles | 2016 |